Immunohistochemical testing of GISTs using CD117 markers: the UK NEQAS ICC & ISH external quality assessment data show significant differences in the performance of methods in regular use.

Br J Biomed Sci · 2026 · PMC13423735 · PMID 42539518

Europe PMC DOI

hedged sentences

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP < 0.0001actually significant

Its performance was superior to that of all other primary reagents, with the difference being significant at P < 0.05 when compared to Y145 and highly significant (P < 0.0001) when compared to both EP (RD) and the polyclonal antiserum.

also in 132,142 other papers

a strong trendno p-value reported

There was a strong trend for the proportion of submissions obtaining a good/excellent quality score to increase over time.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Immunohistochemical testing of GISTs using CD117 markers: the UK NEQAS ICC &amp; ISH external quality assessment data show significant differences in the performance of methods in regular use.

The sentences

Immunohistochemical testing of GISTs using CD117 markers: the UK NEQAS ICC & ISH external quality assessment data show significant differences in the performance of methods in regular use.